Sfoglia per RIVISTA
JOURNAL FOR IMMUNOTHERAPY OF CANCER
Collezione ASL Asti

  

Items : 1

Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Jan;10(1):e003697. doi: 10.1136/jitc-2021-003697.

2022
ASL Asti

de Bono J; Zucali PA; Lépine L; Abbadessa G; Loumagne L; Chiron M; Wang R; Dong Y; Lee H; Meng R; Perrino M; Pant S; Shen YC; Gutierrez M; Daniele G; Greystoke A; Saleh M; Su WC; Massard C; Iacovelli R; Bauer TM; Italiano A; Tucci M; Lin CC; Carthon BC;